GeneDx Holdings Corp. (WGS) Insider Trading
- $4,263,232.78
- $25,082,538.95
- Sept. 9, 2024
- Kevin Feeley
Trader Name | Date | Title | Amount | Price | Type | Total Value |
---|---|---|---|---|---|---|
Sept. 9, 2024 | CEO | 3,639 | $33.33 | Sell | $121,287.87 | |
Sept. 9, 2024 | CFO | 895 | $33.33 | Sell | $29,830.35 | |
Sept. 3, 2024 | CFO | 262 | $31.71 | Sell | $8,308.02 | |
Aug. 19, 2024 | Major Shareholder | 50,000 | $34.49 | Sell | $1,724,500.00 | |
Aug. 15, 2024 | Major Shareholder | 39,824 | $33.08 | Sell | $1,317,377.92 | |
Aug. 12, 2024 | Major Shareholder | 59,787 | $33.95 | Sell | $2,029,768.65 | |
Aug. 8, 2024 | Major Shareholder | 100,000 | $31.82 | Sell | $3,182,000.00 | |
Aug. 6, 2024 | Major Shareholder | 12,994 | $29.35 | Sell | $381,373.90 | |
July 31, 2024 | Major Shareholder | 88,839 | $33.50 | Sell | $2,976,106.50 | |
July 29, 2024 | CFO | 274 | $33.54 | Sell | $9,189.96 | |
July 29, 2024 | CEO | 2,154 | $33.54 | Sell | $72,245.16 | |
July 29, 2024 | Major Shareholder | 50,000 | $33.86 | Sell | $1,693,000.00 | |
July 26, 2024 | Major Shareholder | 60,000 | $33.85 | Sell | $2,031,000.00 | |
July 24, 2024 | Major Shareholder | 75,000 | $33.72 | Sell | $2,529,000.00 | |
July 22, 2024 | Major Shareholder | 50,000 | $32.61 | Sell | $1,630,500.00 | |
July 19, 2024 | Major Shareholder | 25,000 | $32.29 | Sell | $807,250.00 | |
July 17, 2024 | Major Shareholder | 25,000 | $32.93 | Sell | $823,250.00 | |
July 5, 2024 | Major Shareholder | 36,118 | $28.24 | Sell | $1,019,972.32 | |
July 3, 2024 | Major Shareholder | 14,082 | $28.23 | Sell | $397,534.86 | |
July 1, 2024 | Major Shareholder | 50,000 | $26.63 | Sell | $1,331,500.00 | |
June 17, 2024 | CFO | 2,646 | $28.31 | Sell | $74,908.26 | |
June 17, 2024 | CEO | 7,683 | $28.31 | Sell | $217,505.73 | |
June 10, 2024 | CFO | 895 | $24.92 | Sell | $22,303.40 | |
June 10, 2024 | CEO | 2,652 | $24.92 | Sell | $66,087.84 | |
June 3, 2024 | Director | 100,000 | $20.82 | Buy | $2,082,000.00 | |
May 28, 2024 | Director | 18,304 | $20.61 | Buy | $377,245.44 | |
May 23, 2024 | Director | 7,500 | $19.59 | Buy | $146,925.00 | |
May 13, 2024 | Director | 50,000 | $23.31 | Buy | $1,165,500.00 | |
April 29, 2024 | CEO | 6,325 | $11.04 | Sell | $69,828.00 | |
April 29, 2024 | CFO | 1,104 | $11.04 | Sell | $12,188.16 | |
March 18, 2024 | CEO | 8,559 | $10.59 | Sell | $90,639.81 | |
March 18, 2024 | Insider | 2,008 | $10.59 | Sell | $21,264.72 | |
March 18, 2024 | CFO | 3,253 | $10.59 | Sell | $34,449.27 | |
March 4, 2024 | Director | 40,000 | $8.74 | Buy | $349,600.00 | |
Jan. 22, 2024 | Insider | 193 | $3.24 | Sell | $625.32 | |
Jan. 3, 2024 | Insider | 105 | $2.58 | Sell | $270.90 | |
Dec. 18, 2023 | CFO | 2,948 | $2.16 | Sell | $6,367.68 | |
Dec. 18, 2023 | Insider | 1,700 | $2.16 | Sell | $3,672.00 | |
Dec. 18, 2023 | CEO | 11,734 | $2.16 | Sell | $25,345.44 | |
Dec. 4, 2023 | CFO | 270 | $1.77 | Sell | $477.90 | |
Nov. 16, 2023 | Chairman | 56,742 | $1.27 | Buy | $72,062.34 | |
Nov. 8, 2023 | Director | 10,000 | $1.49 | Buy | $14,900.00 | |
Oct. 20, 2023 | Insider | 164 | $3.44 | Sell | $564.16 | |
Oct. 17, 2023 | Chairman | 42 | $3.19 | Sell | $133.98 | |
Oct. 3, 2023 | Insider | 85 | $3.56 | Sell | $302.60 | |
Sept. 18, 2023 | Insider | 1,580 | $4.16 | Sell | $6,572.80 | |
Sept. 18, 2023 | CEO | 10,752 | $4.16 | Sell | $44,728.32 | |
Sept. 18, 2023 | CFO | 2,742 | $4.16 | Sell | $11,406.72 | |
Sept. 11, 2023 | CEO | 2,675 | $4.62 | Sell | $12,358.50 | |
Sept. 11, 2023 | CFO | 904 | $4.62 | Sell | $4,176.48 |
Insiders are both buying and selling GeneDx Holdings Corp. stock.
The insider traders at GeneDx Holdings Corp. are: Kevin Feeley, Opko Health, Inc., Katherine Stueland, Kareem Saad, Karen Ann White, Casdin Capital, Llc, Richard C Pfenniger Jr, and Jason Ryan
The most active insider trader at GeneDx Holdings Corp. is Kevin Feeley with 17 trades.
Opko Health, Inc. has sold the most GeneDx Holdings Corp. stock with a total value of $25,598,634.15.
Casdin Capital, Llc has bought the most GeneDx Holdings Corp. stock with a total value of $6,203,270.44.
The most recent insider trade for GeneDx Holdings Corp. was on Sept. 9, 2024.
The single biggest insider buy for GeneDx Holdings Corp. was from Casdin Capital, Llc with a total value of $2,082,000.00 on June 3, 2024.
The single biggest insider sell for GeneDx Holdings Corp. was from Opko Health, Inc. with a total value of $3,182,000.00 on Aug. 8, 2024.